ASRT Assertio Holdings Inc.

Assertio to Participate in the 2022 Lake Street BIG6 Conference

Assertio to Participate in the 2022 Lake Street BIG6 Conference

LAKE FOREST, Ill., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, will host investor meetings September 14, 2022 as part of the Lake Street Capital Markets Best Ideas Growth Conference (BIG6), taking place at The Yale Club in New York City.

As part of the conference event, management will host one-on-one meetings throughout the day.

For more information about scheduling a one-on-one meeting with management, please contact your Lake Street representative or Matt Kreps, Investor Relations for Assertio Holdings, at .

About Assertio

Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: .

Investor Contact:

Matt Kreps

Managing Director

Darrow Associates

Austin, TX

M: 214-597-8200



EN
07/09/2022

Underlying

ASRTAssertio Holdings Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Assertio Holdings Inc.

 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports First Quarter 2025 Financial Results

Assertio Reports First Quarter 2025 Financial Results First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the first quarter ende...

May 12, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and update the Company’s 2025 strategic plans. To access the live webcast, conference call information, and other materials, ...

May 5, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio to Participate in the iAccess Alpha Virtual Best Ideas Confer...

Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025 LAKE FOREST, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the iAccess Alpha Best Ideas Spring Investment Conference taking place virtually March 25-26, 2025. The Company will present at 1:30 pm Eastern Time on Tuesday, March 25, 2025. To join the presentation, please visit the webcast available online at . Additionally, investors participating in the ...

March 20, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

Assertio Reports Fourth Quarter and Full Year 2024 Financial Results Fourth Quarter Net Product Sales $29.6 Million, Cash Flow from Operations of $11.5 Million Full Year Net Product Sales $120.8 Million, Rolvedon Sales Exceed $60.0 Million Full Year Cash Flow from Operations of $26.4 Million, Cash and Investments Increases to $100.1 Million LAKE FOREST, Ill., March 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today reported financial results for the fourth quarter and full year ended December 31, 2024. Said Brendan ...

March 12, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Fi...

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 LAKE FOREST, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time. To access the live webcast, conference call information, and other m...

March 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch